Search Results

Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT

• Authors : Paviglianiti, Annalisa; Labopin, Myriam; Blaise, Didier

• Source: Bone Marrow Transplantation. May, 2021, Vol. 56 Issue 5, p1077, 9 p.

Record details

Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT.

• Authors : Kakihana, K¹; Ohashi, K¹; Murata, Y¹

Subjects: *LETTERS to the editor; *CALCINEURIN; *STEM cell transplantation

• Source: Bone Marrow Transplantation. Apr2012, Vol. 47 Issue 4, p593-595. 3p. 1 Black and White Photograph, 1 Chart.

Record details

Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

• Authors : Maples, Kathryn T.; Maloy, Molly; Devlin, Sean

• Source: Bone Marrow Transplantation. August, 2020, Vol. 55 Issue 8, p1687, 3 p.

Record details

Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients

• Authors : Mori, T.; Aisa, Y.; Kato, J.

• Source: Bone Marrow Transplantation. Sept 2, 2009, Vol. 44 Issue 6, p371, 4 p.

Record details

Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis

• Authors : Ikezoe, T; Yang, J; Nishioka, C

• Source: Bone Marrow Transplantation. February, 2017, Vol. 52 Issue 2, p245

Record details

Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients

• Authors : Onizuka, M.; Kunii, N.; Toyosaki, M.

• Source: Bone Marrow Transplantation. August, 2011, Vol. 46 Issue 8, p1113, 5 p.

Record details

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study

• Authors : Schleuning, M.; Judith, D.; Jedlickova, Z.

• Source: Bone Marrow Transplantation. May 1, 2009, Vol. 43 Issue 9, p717, 7 p.

Record details

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma.

• Authors : Raiola, A¹; Dominietto, A¹; Varaldo, R¹

Subjects: *HODGKIN'S disease treatment; *CALCINEURIN; *CHEMICAL inhibitors

• Source: Bone Marrow Transplantation. Feb2014, Vol. 49 Issue 2, p190-194. 5p. 1 Chart, 3 Graphs.

Record details

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

• Authors : Rimondo, A; Crocchiolo, R; El-Cheikh, J

• Source: Bone Marrow Transplantation. January, 2017, Vol. 52 Issue 1, p135

Record details

Generation of EBV CTL resistant to calcineurin inhibitors for treatment of post transplant lymphoproliferative disease

• Authors : Brewin, J.; Straathof, K.; Karlsson, H.

• Source: Bone Marrow Transplantation. March 2009, Vol. 43 Issue S1, pS74, 1 p.

Record details